Arcutis Biotherapeutics, Inc. ARQT Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s accrued expenses?
- Arcutis Biotherapeutics, Inc. (ARQT) reported accrued expenses of $10.32M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s accrued expenses changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s accrued expenses increased by 12.7% year-over-year, from $9.16M to $10.32M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s accrued expenses has grown at a 35.9% compound annual growth rate (CAGR), from $4.43M to $20.53M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.